Page last updated: 2024-12-06

bicarphene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

bicarphene: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID42553
CHEMBL ID2105505
SCHEMBL ID1813871
SCHEMBL ID11761803
MeSH IDM0069397

Synonyms (35)

Synonym
benzhydrol, 2,2'-dimethyl-alpha-(3-quinuclidinyl)-
sequifenadina [spanish]
sequifenadine [inn]
bicarphene
3-quinuclidinemethanol, alpha,alpha-di-o-tolyl-
sequifenadine
brn 1548429
sequifenadinum [latin]
alpha,alpha-di-o-tolyl-3-quinuclidinemethanol
STL026230
1-azabicyclo[2.2.2]oct-3-yl[bis(2-methylphenyl)]methanol
1-azabicyclo[2.2.2]octan-3-yl-bis(2-methylphenyl)methanol
1-azabicyclo[2.2.2]oct-3-yl[bis(2-methylphenyl)]methanol hydrochloride
sequifenadinum
57734-69-7
sequifenadina
c7q3tbr3fp ,
unii-c7q3tbr3fp
CHEMBL2105505
AKOS005174257
D10510
AB01321356-02
sequifenadine [who-dd]
sequifenadine [mart.]
SCHEMBL1813871
SCHEMBL11761803
SR-01000944892-1
sr-01000944892
Q4418107
DB13566
NCGC00326051-01
(1-azabicyclo[2.2.2]octan-3-yl)bis(2-methylphenyl)methanol
DTXSID40866647
CS-0326942
HY-W281862
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (62.50)18.7374
1990's3 (37.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (18.18%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (18.18%)4.05%
Observational0 (0.00%)0.25%
Other7 (63.64%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]